METOXI-POLIETILENGLICOL EPOETINA BETA (MIRCERA®) EN EL TRATAMIENTO DE UNA PACIENTE CON ENFERMEDAD RENAL CRÓNICA Y QUE PRESENTA HIPERSENSIBILIDAD RETARDADA A OTRAS EPOETINAS
Methoxy polyethylene glycol-epoetin beta in the treatment of a patient with chronic kidney disease presenting late-onset hypersensitivity to other epoetins
Leído
35996
Vecesse ha leído el artículo
3313
Total PDF
32683
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 84 | 9 | 93 |
| 2025 5 | 306 | 40 | 346 |
| 2025 4 | 357 | 30 | 387 |
| 2025 3 | 434 | 62 | 496 |
| 2025 2 | 401 | 33 | 434 |
| 2025 1 | 310 | 34 | 344 |
| 2024 12 | 307 | 39 | 346 |
| 2024 11 | 284 | 70 | 354 |
| 2024 10 | 337 | 40 | 377 |
| 2024 9 | 277 | 26 | 303 |
| 2024 8 | 250 | 62 | 312 |
| 2024 7 | 241 | 38 | 279 |
| 2024 6 | 213 | 49 | 262 |
| 2024 5 | 314 | 44 | 358 |
| 2024 4 | 221 | 56 | 277 |
| 2024 3 | 226 | 43 | 269 |
| 2024 2 | 266 | 48 | 314 |
| 2024 1 | 389 | 49 | 438 |
| 2023 12 | 319 | 40 | 359 |
| 2023 11 | 341 | 43 | 384 |
| 2023 10 | 361 | 42 | 403 |
| 2023 9 | 409 | 39 | 448 |
| 2023 8 | 354 | 32 | 386 |
| 2023 7 | 260 | 40 | 300 |
| 2023 6 | 289 | 29 | 318 |
| 2023 5 | 300 | 54 | 354 |
| 2023 4 | 297 | 39 | 336 |
| 2023 3 | 321 | 46 | 367 |
| 2023 2 | 209 | 35 | 244 |
| 2022 1 | 231 | 37 | 268 |
| 2022 12 | 160 | 40 | 200 |
| 2022 11 | 281 | 46 | 327 |
| 2022 10 | 360 | 78 | 438 |
| 2022 9 | 290 | 49 | 339 |
| 2022 8 | 250 | 60 | 310 |
| 2022 7 | 197 | 43 | 240 |
| 2022 6 | 163 | 48 | 211 |
| 2022 5 | 166 | 43 | 209 |
| 2022 4 | 209 | 59 | 268 |
| 2022 3 | 188 | 59 | 247 |
| 2022 2 | 203 | 61 | 264 |
| 2021 1 | 166 | 62 | 228 |
| 2021 12 | 129 | 57 | 186 |
| 2021 11 | 176 | 42 | 218 |
| 2021 10 | 269 | 61 | 330 |
| 2021 9 | 196 | 48 | 244 |
| 2021 8 | 211 | 39 | 250 |
| 2021 7 | 248 | 39 | 287 |
| 2021 6 | 194 | 30 | 224 |
| 2021 5 | 212 | 35 | 247 |
| 2021 4 | 431 | 59 | 490 |
| 2021 3 | 413 | 29 | 442 |
| 2021 2 | 323 | 33 | 356 |
| 2020 1 | 207 | 27 | 234 |
| 2020 12 | 227 | 19 | 246 |
| 2020 11 | 162 | 14 | 176 |
| 2020 10 | 184 | 15 | 199 |
| 2020 9 | 269 | 10 | 279 |
| 2020 8 | 261 | 7 | 268 |
| 2020 7 | 260 | 10 | 270 |
| 2020 6 | 277 | 12 | 289 |
| 2020 5 | 295 | 32 | 327 |
| 2020 4 | 388 | 20 | 408 |
| 2020 3 | 459 | 27 | 486 |
| 2020 2 | 499 | 37 | 536 |
| 2020 1 | 492 | 30 | 522 |
| 2019 12 | 361 | 23 | 384 |
| 2019 11 | 468 | 37 | 505 |
| 2019 10 | 509 | 19 | 528 |
| 2019 9 | 508 | 37 | 545 |
| 2019 8 | 477 | 24 | 501 |
| 2019 7 | 461 | 21 | 482 |
| 2019 6 | 411 | 16 | 427 |
| 2019 5 | 463 | 19 | 482 |
| 2019 4 | 484 | 36 | 520 |
| 2019 3 | 433 | 32 | 465 |
| 2019 2 | 253 | 23 | 276 |
| 2019 1 | 260 | 25 | 285 |
| 2018 12 | 542 | 37 | 579 |
| 2018 11 | 393 | 19 | 412 |
| 2018 10 | 365 | 14 | 379 |
| 2018 9 | 253 | 23 | 276 |
| 2018 8 | 198 | 17 | 215 |
| 2018 7 | 170 | 15 | 185 |
| 2018 6 | 168 | 14 | 182 |
| 2018 5 | 186 | 23 | 209 |
| 2018 4 | 132 | 19 | 151 |
| 2018 3 | 157 | 21 | 178 |
| 2018 2 | 183 | 8 | 191 |
| 2018 1 | 119 | 12 | 131 |
| 2017 12 | 96 | 5 | 101 |
| 2017 11 | 80 | 8 | 88 |
| 2017 10 | 73 | 8 | 81 |
| 2017 9 | 68 | 12 | 80 |
| 2017 8 | 80 | 14 | 94 |
| 2017 7 | 76 | 14 | 90 |
| 2017 6 | 81 | 6 | 87 |
| 2017 5 | 53 | 6 | 59 |
| 2017 4 | 46 | 8 | 54 |
| 2017 3 | 62 | 5 | 67 |
| 2017 2 | 58 | 3 | 61 |
| 2016 1 | 74 | 12 | 86 |
| 2016 12 | 56 | 7 | 63 |
| 2016 11 | 69 | 18 | 87 |
| 2016 10 | 69 | 14 | 83 |
| 2016 9 | 91 | 5 | 96 |
| 2016 8 | 148 | 3 | 151 |
| 2016 7 | 109 | 3 | 112 |
| 2016 6 | 97 | 0 | 97 |
| 2016 5 | 125 | 0 | 125 |
| 2016 4 | 76 | 0 | 76 |
| 2016 3 | 87 | 0 | 87 |
| 2016 2 | 85 | 0 | 85 |
| 2015 1 | 105 | 0 | 105 |
| 2015 12 | 110 | 0 | 110 |
| 2015 11 | 86 | 0 | 86 |
| 2015 10 | 95 | 0 | 95 |
| 2015 9 | 54 | 0 | 54 |
| 2015 8 | 74 | 0 | 74 |
| 2015 7 | 57 | 0 | 57 |
| 2015 6 | 32 | 0 | 32 |
| 2015 5 | 77 | 0 | 77 |
| 2015 4 | 7 | 0 | 7 |
| 2015 2 | 3850 | 0 | 3850 |
Mostrar todo
